A multicenter, randomized, double-blind, eight week comparative efficacy and safety study of H 199/18 20 mg and omeprazole 20 mg in study subjects with erosive esophagitis

Study identifier:SH-QBE-0017

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A multicenter, randomized, double-blind, eight week comparative efficacy and safety study of H 199/18 20 mg and omeprazole 20 mg in study subjects with erosive esophagitis

Medical condition

gastrointestinal diseases

Phase

N/A

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jan 1971

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2358&filename=CSR-SH-QBE-0017.pdf
Download
CSR-SH-QBE-0017.pdf
Download
Trial Results Summaries
Available here

A multicenter, randomized, double-blind, eight week comparative efficacy and safety study of H 199/18 20 mg and omeprazole 20 mg in study subjects with erosive esophagitis

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2358&filename=CSR-SH-QBE-0017.pdf

CSR-SH-QBE-0017.pdf

Trial Results Summaries